Blueprint Medicines, a Sanofi company, today announced updated data reinforcing the clinical efficacy and safety of long-term ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

Artificial intelligence could further widen race-based disparities in healthcare, the organization says. Its new blueprint is meant as a first step in a larger, more ambitious campaign to ensure that ...

Cogent Biosciences (COGT) shares have surged after pivotal bezuclastinib data in imatinib-resistant aGIST. Read the latest ...

The NAACP unveiled a blueprint on Wednesday aimed at preventing artificial intelligence from deepening racial inequities in U ...

Dec 11 (Reuters) - The NAACP unveiled a blueprint on Wednesday aimed at ‌preventing ​artificial intelligence from deepening ...

Large M&A transactions and bidding wars for Metsera and Avadel announced in H2 2025 reflect a need for large pharma companies to replenish pipelines through M&A ahead of looming patent cliffs.

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While ...

In this video, Jonathan A. Bernstein, MD, discusses findings about chronic itch presented at the American College of Allergy, ...

REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in preclinical models ...

M&A in biopharma is shaped by policy uncertainties, tariffs, and potential marketing rule changes, influencing strategic ...

In this video, Jonathan A. Bernstein, MD, discusses an American College of Allergy, Asthma & Immunology Annual Scientific ...